Trademark: 97470839
Word
B
Status
Pending
Status Code
731
Status Date
Thursday, February 8, 2024
Serial Number
97470839
Mark Type
3000
Filing Date
Wednesday, June 22, 2022
Published for Opposition
Tuesday, January 17, 2023

Trademark Owner History
BridgeBio Pharma, Inc. - Owner At Publication

Classifications
5 Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
42 Pharmaceutical research and development services
BRIDGEBIO; BRIDGE BIO
Color is not claimed as a feature of the mark.

Trademark Events
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2024
Sou Extension 2 Granted
Feb 8, 2024
Sou Extension 2 Filed
Feb 8, 2024
Sou Teas Extension Received
Aug 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2023
Sou Extension 1 Granted
Aug 11, 2023
Sou Extension 1 Filed
Aug 11, 2023
Sou Teas Extension Received
Mar 14, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 17, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 17, 2023
Published For Opposition
Dec 28, 2022
Notification Of Notice Of Publication E-Mailed
Dec 13, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 13, 2022
Teas Change Of Correspondence Received
Dec 13, 2022
Teas Change Of Owner Address Received
Dec 13, 2022
Approved For Pub - Principal Register
Dec 11, 2022
Assigned To Examiner
Jul 12, 2022
Notice Of Design Search Code E-Mailed
Jul 11, 2022
New Application Office Supplied Data Entered
Jun 25, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24